TF and cancer: Finally, EGFR-induced signaling in glioma cells stimulates expression of TF, FVII, and PAR-2, thereby increasing TF/VIIa-mediated PAR-2 activation in cancer cells [115], and cancer cells may secrete aFVII that can act alone to activate PAR-2 [116].